IUPHAR’s scientific and strategic activities are organized through dedicated Sections and their associated Committees.
Each Section represents a core area of pharmacology and provides leadership, coordination, and expertise within its field.
Committees operate within these Sections to address specific scientific, educational, and governance topics. They are composed of international experts who contribute to IUPHAR’s mission through research, education, collaboration, and policy development.
This structure ensures a clear distribution of responsibilities, promotes interdisciplinary exchange, and supports the global pharmacology community through transparent and effective governance.
Below you can explore each Section in detail, including its scope, leadership, and the members of the corresponding Committees.
Clinical pharmacology focuses on how medicines interact with humans, bridging research, healthcare, and real-world patient care. Through scientific expertise and clinical insight, this field supports the development of better therapies and the safer, more effective use of medicines in everyday practice.
Clinical pharmacology focuses on how medicines interact with humans, bridging research, healthcare, and real-world patient care. Through scientific expertise and clinical insight, this field supports the development of better therapies and the safer, more effective use of medicines in everyday practice.
The Early Career Researchers Section brings together emerging scientists at the start of their careers in pharmacology. It serves as a global platform to connect early-career researchers with the wider IUPHAR community and the international pharmacology ecosystem.
Through shared initiatives and cross-border collaboration, the section helps build strong foundations for the next generation of pharmacological research and leadership.
The Early Career Researchers Section brings together emerging scientists at the start of their careers in pharmacology. It serves as a global platform to connect early-career researchers with the wider IUPHAR community and the international pharmacology ecosystem.
Through shared initiatives and cross-border collaboration, the section helps build strong foundations for the next generation of pharmacological research and leadership.
The NC‑IUPHAR Section leads the international standardization of pharmacological nomenclature and classification, providing authoritative frameworks for biological targets and drug interactions.
Through expert-driven guidelines and the development of the Guide to Pharmacology, it supports research, education, and innovation by ensuring clarity, consistency, and accessibility across the global pharmacology community within IUPHAR.
The NC‑IUPHAR Section leads the international standardization of pharmacological nomenclature and classification, providing authoritative frameworks for biological targets and drug interactions.
Through expert-driven guidelines and the development of the Guide to Pharmacology, it supports research, education, and innovation by ensuring clarity, consistency, and accessibility across the global pharmacology community within IUPHAR.
IUPHAR-Ed is a dynamic global community of educators in basic, clinical and translational fields of pharmacology.
We have recently introduced new initiatives to actively promote access to educational materials, collaboratively develop new resources, discuss matters related to pharmacology education and more.
IUPHAR-Ed is a dynamic global community of educators in basic, clinical and translational fields of pharmacology.
We have recently introduced new initiatives to actively promote access to educational materials, collaboratively develop new resources, discuss matters related to pharmacology education and more.
The Basic and Translational Section brings together core areas of pharmacology that bridge fundamental discovery and real-world application.
Through its committees, the Section supports collaboration, methodological rigor, and the translation of biological insight into better therapeutic strategies across diverse disease areas.
The Basic and Translational Section brings together core areas of pharmacology that bridge fundamental discovery and real-world application.
Through its committees, the Section supports collaboration, methodological rigor, and the translation of biological insight into better therapeutic strategies across diverse disease areas.